1. Home
  2. CNVS vs SCLX Comparison

CNVS vs SCLX Comparison

Compare CNVS & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNVS
  • SCLX
  • Stock Information
  • Founded
  • CNVS 2000
  • SCLX 2011
  • Country
  • CNVS United States
  • SCLX United States
  • Employees
  • CNVS N/A
  • SCLX N/A
  • Industry
  • CNVS Consumer Electronics/Video Chains
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNVS Consumer Discretionary
  • SCLX Health Care
  • Exchange
  • CNVS Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • CNVS 56.6M
  • SCLX 51.3M
  • IPO Year
  • CNVS 2003
  • SCLX N/A
  • Fundamental
  • Price
  • CNVS $3.16
  • SCLX $0.23
  • Analyst Decision
  • CNVS Buy
  • SCLX Strong Buy
  • Analyst Count
  • CNVS 1
  • SCLX 4
  • Target Price
  • CNVS $10.00
  • SCLX $14.00
  • AVG Volume (30 Days)
  • CNVS 71.9K
  • SCLX 1.1M
  • Earning Date
  • CNVS 02-13-2025
  • SCLX 05-12-2025
  • Dividend Yield
  • CNVS N/A
  • SCLX N/A
  • EPS Growth
  • CNVS N/A
  • SCLX N/A
  • EPS
  • CNVS N/A
  • SCLX N/A
  • Revenue
  • CNVS $72,469,000.00
  • SCLX $55,152,000.00
  • Revenue This Year
  • CNVS $59.61
  • SCLX $24.19
  • Revenue Next Year
  • CNVS N/A
  • SCLX $109.90
  • P/E Ratio
  • CNVS N/A
  • SCLX N/A
  • Revenue Growth
  • CNVS 39.86
  • SCLX 22.02
  • 52 Week Low
  • CNVS $0.72
  • SCLX $0.21
  • 52 Week High
  • CNVS $4.89
  • SCLX $2.30
  • Technical
  • Relative Strength Index (RSI)
  • CNVS 35.69
  • SCLX 30.70
  • Support Level
  • CNVS $3.37
  • SCLX $0.22
  • Resistance Level
  • CNVS $3.65
  • SCLX $0.34
  • Average True Range (ATR)
  • CNVS 0.20
  • SCLX 0.03
  • MACD
  • CNVS -0.03
  • SCLX -0.00
  • Stochastic Oscillator
  • CNVS 17.11
  • SCLX 8.47

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: